Home › Funds › G&S Capital LLC › ABBV

G&S Capital LLC position in ABBV

ABBVIE INC · Health Care

G&S Capital LLC reported holding 18,510 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$4.8M, representing 1.56% of its reported portfolio and ranking #12 among its reported holdings. G&S Capital LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)18.51K sh
Reported value held$4.84M
Portfolio Weight1.56%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How G&S Capital LLC's ABBV position evolved

G&S Capital LLC first disclosed a stake in ABBV in Q3 2023 at 5,785 shares (US$862K). The position peaked in Q3 2026 at 18,510 shares, worth US$4.8M. Across 13 filings, G&S Capital LLC increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 18,510 shares valued at US$4.8M — an increase of 118 shares quarter over quarter.. Notable position changes include a 268% increase in Q4 2024 (shares rose 19% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 5.79K $862.31K New
Q4 2023 5.92K $917.50K Add
Q1 2024 5.84K $1.06M Reduce
Q2 2024 5.73K $962.99K Reduce
Q3 2024 5.78K $1.14M Add
Q4 2024 21.27K $3.78M Add
Q1 2025 18.45K $3.87M Reduce
Q2 2025 18.75K $3.48M Add
Q3 2025 18.85K $4.36M Hold
Q4 2025 17.69K $4.04M Reduce
Q1 2026 18.24K $3.97M Add
Q2 2026 18.39K $4.63M Add
Q3 2026 18.51K $4.84M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has G&S Capital LLC held ABBV?

G&S Capital LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is G&S Capital LLC's current position in ABBV?

As of Q3 2026, G&S Capital LLC holds 18.51K shares of ABBV (ABBVIE INC), valued at $4.84M, representing 1.56% of its reported portfolio and ranking #12.

Has G&S Capital LLC been buying or selling ABBV?

In the latest 13F filing (Q3 2026), G&S Capital LLC increased its position in ABBV. The position peaked in Q3 2026 at 18.51K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.